Please login to the form below

Not currently logged in


This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

Orphan status in Europe for lymphoma drug Zynlonta

Orphan status in Europe for lymphoma drug Zynlonta

In exchange for a 7% royalty on worldwide net sales and licensing revenue from Zynlonta and Cami, ADC will receive $225m upfront, $75m following the first commercial sale of Zynlonta in

Latest news

More from news
Approximately 10 fully matching, plus 636 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 105 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 44 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...